Skip to main content
Alzheimer's Research & Therapy logoLink to Alzheimer's Research & Therapy
. 2023 Sep 29;15:162. doi: 10.1186/s13195-023-01313-7

Retraction Note: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis

Panchanan Maiti 1,2,3,4,5,, Zackary Bowers 1,2, Ali Bourcier-Schultz 5, Jarod Morse 5, Gary L Dunbar 1,2,3,4,
PMCID: PMC10542674  PMID: 37773163

Retraction Note: Alz Res Ther 13, 37 (2021)

https://doi.org/10.1186/s13195-021-00769-9

The Editors-in-Chief have retracted this article at the authors' request. After publication, concerns were raised regarding a number of cases of image overlap within the Figures, which the authors addressed by a Correction [1]. However, subsequent concerns have been raised about further image similarities within the article, as well as with previous studies. Specifically:

  • Fig. 3b 5xFAD + Veh CAI 12-month-old group image appears highly similar to an image representing the same group in [2].

  • In Fig. 3B, 5xFAD + SCLP Cortex and Entorhinal cortex images appear to originate from the same sample.

  • In Fig. 3E, the beta-tubulin blots presented for the cortex 6- and 12-month-old groups appear highly similar; the beta-tubulin blot image for hippocampus in the 6-month-old group appears highly similar to that representing beta-tubulin in the 12-month-old group in Figs. 5F and 7A.

  • The updated Fig. 4G 5xFAD Primary 6-month-old group image appears to overlap with Fig. 4I 5xFAD Secondary 12-month-old group.

  • The top beta-tubulin blot in Fig. 6F appears highly similar to the beta-tubulin (hippocampus) blot in Fig. 7A.

  • The blots in Fig. S2I appear highly similar to those in Fig. 3D of [3, now retracted].

  • Fig. S5A appears highly similar to the Merged 5xFAR + SLCP (2d) image in Fig. 1B of [3, now retracted].

Despite internal data validation, the authors no longer have sufficient confidence in the findings of this study.

All authors agree to this retraction.

Contributor Information

Panchanan Maiti, Email: maiti1p@cmich.edu.

Gary L. Dunbar, Email: dunba1g@cmich.edu

References

  • 1.Maiti P, Bowers Z, Bourcier-Schultz A, et al. Correction to: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis. Alz Res Ther. 2022;14:42. doi: 10.1186/s13195-022-00980-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Maiti P, Manna J, Burch ZN, et al. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease. Int J Mol Sci. 2020;21(18):6664. doi: 10.3390/ijms21186664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Maiti P, Paladugu L, Dunbar GL. RETRACTED ARTICLE: Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer’s disease. BMC Neurosci. 2018;19:7. doi: 10.1186/s12868-018-0406-3. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Alzheimer's Research & Therapy are provided here courtesy of BMC

RESOURCES